Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Motor Activity 2Leukemia, Myeloid, Acute 2Postoperative Cognitive Complications 1Neoplasms 1Malnutrition 1Liver Diseases 1Gastrointestinal Neoplasms 1Frailty 1Emergence Delirium 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Breast Cancer Female 1

Interventions

Specimen Handling 4Fluorouracil 4Bevacizumab 4fludarabine 3aldesleukin 3Radiosurgery 3Gemcitabine 3Endoscopic Mucosal Resection 3Cyclophosphamide 3Cetuximab 3130-nm albumin-bound paclitaxel 3Surveys and Questionnaires 2Sunitinib 2Pemetrexed 2Oxaliplatin 2Leucovorin 2IDRX-42 2Folfox protocol 2trastuzumab deruxtecan 1tislelizumab 1sodium thiosulfate 1sodium propionate 1semaglutide 1repotrectinib 1plecanatide 1pembrolizumab 1patritumab deruxtecan 1palbociclib 1linaclotide 1isosorbide-5-mononitrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × Control Groups × 90 days × Clear all
NCT06551675 2026-05-27

Effect of Silkworm Pupa Tablets in Gastrointestinal Malignancies at Nutritional Risk Following Radical Surgery

First Affiliated Hospital of Zhejiang University

Phase NA Completed
120 enrolled
Gastrointestinal

Frailty, Gastrointestinal Neoplasms, Malnutrition

Data powered by HemOnc (CC BY 4.0) Colophon âš¡